Jamie Cesanek

February 22, 2022

The goal of the phase 2 trial is to study the safety and efficacy of ASP-1929, a photoimmunotherapy with fluorescence imaging, in patients with head and neck or skin cancer.

February 21, 2022

New research has demonstrated that treatment with Rozlytrek induced meaningful responses in patients with NTRK fusion-positive solid tumors and may also effectively treat brain metastases in those patients.

February 18, 2022

From NBC4 meteorologist Bob Nunnally’s break for cancer treatments to Mary J. Blige’s Super Bowl commercial encouraging others to undergo cancer screenings, here’s what’s happening in the cancer landscape this week.

February 17, 2022

A trial to examine BMF-219 in patients with relapsed or refractory acute leukemias has begun recruiting patients across multiple U.S. states.

February 17, 2022

In this episode of the “Cancer Horizons” podcast, the founder of Jack’s Caregiver Coalition, a nonprofit organization dedicated to supporting men throughout the caregiving experience, explores the layered sociological factors which can affect men in unique ways when they are supporting a loved one with cancer.

February 11, 2022

From an Olympic gold medal win for cancer survivor Max Parrot to Sofía Vergara’s candidness about her cancer journey, here’s what’s happening in the cancer landscape this week.

February 10, 2022

On this episode of the “Cancer Horizons” podcast, former NFL linebacker Chris Draft discusses his wife’s experience with cancer, which led to her untimely death, and describes why advocacy is so important in the cancer world, especially with Cancer Moonshot bringing disparities to the forefront.

February 09, 2022

A phase 3 trial evaluating the safety and efficacy of the BTK inhibitor LOXO-305 in patients with previously treated mantle cell lymphoma is now open to patients across more than a dozen states.

February 08, 2022

Results from the SIENDO trial examining the effects of Xpovio as a frontline maintenance therapy in patients with advanced or recurrent endometrial cancer highlighted a significant survival benefit.

February 07, 2022

A phase 2b clinical trial evaluating the efficacy and safety of an immunotherapy drug for patients with brain cancer has opened at Roswell Park Comprehensive Cancer Center in Buffalo, New York, with additional plans to be carried out at more than a dozen sites.

February 04, 2022

From the death of a former New York Mets player due to cancer, to a lawsuit against Tokyo Electric Power Company Holdings regarding cancer potentially caused by the 2011 Fukushima nuclear disaster, here’s what’s happening in the cancer landscape this week.

February 03, 2022

On this episode of the “Cancer Horizons” podcast, a cancer nurse explains how her son’s leukemia diagnosis transformed her work, her research and her outlook on life.

February 03, 2022

With newer treatments like Keytruda (pembrolizumab) approved for patients with cervical cancer, a younger patient population may be concerned about experiencing side effects that interrupt their lives — but if they occur, clinicians will be ready with a plan for management, says an expert from the Uniformed Services University of the Health Sciences.

February 01, 2022

A phase 1/2a clinical trial examining the effects of a treatment called LAVA-1207 for patients with metastatic prostate cancer has now begun.

February 01, 2022

Patient sensitivity to chemotherapy prior to surgery could determine if a patient with gastric cancer needs to receive chemo after surgery.

January 28, 2022

Patients who limit alcohol intake during their cancer treatment may experience several health benefits, according to physicians from Tampa Bay Radiation Oncology.

January 28, 2022

From the lung cancer death of “Seinfeld” actress Kathryn Kates to a patient with cancer who broke a rowing world record, here’s what’s happening in the cancer landscape this week.

January 28, 2022

All clinical trials investigating the combination of magrolimab and the chemotherapy Onureg have been paused due to unforeseen serious side effects experienced by patients with various blood cancers receiving the treatment.

January 27, 2022

In this episode of the “Cancer Horizons” podcast, a woman living with colorectal cancer who was diagnosed 14 years ago at age 29 discusses what it was like to be the youngest person in the treatment room, and how she found another community of young survivors.

January 27, 2022

A clinical trial to evaluate Descartes-25, a novel allogeneic RNA cell therapy, for multiple myeloma has officially treated its first patient and is now recruiting in certain locations.

January 26, 2022

From mental impacts such as “scanxiety” and post-traumatic stress disorder to difficulties returning to work/dating and long-term physical side effects like memory issues, several cancer survivors shared the hardest part about survivorship.

January 25, 2022

Patients with metastatic cutaneous squamous cell carcinoma achieved promising response rates after treatment with cosibelimab. If approved, drug developers are hoping to offer cosibelimab as a more affordable immunotherapy option for this patient population.

January 22, 2022

Treating patients with liver cancer initially with Lenvima instead of the standard of care was associated with a survival benefit, according to recent research.

January 21, 2022

From the death of comedian Louie Anderson after he was hospitalized for cancer treatment to former world No.1 tennis player Chris Evert’s ovarian cancer diagnosis, here’s what’s happening in the cancer landscape this week.

January 21, 2022

Researchers plan to enroll 60 patients in the first-in-human phase 1 clinical trial to assess the safety and preliminary clinical activity of an anti-CD39 monoclonal antibody to treat advanced solid tumors.

January 20, 2022

Recent study results showed that the use of a remote monitoring device worn on the upper arm may help patients with blood cancers seek assistance for serious complications while receiving intensive treatments.

January 20, 2022

In this episode of the “Cancer Horizons” podcast, a cervical cancer survivor and advocate explains how she navigated being given six to 24 months to live as a single mother of three children and no health insurance.

January 19, 2022

A new study to evaluate the accuracy of a blood test for detecting lung cancer in high-risk adults has enrolled its first participant with plans to enroll thousands more.

January 18, 2022

A booster dose of the COVID-19 mRNA vaccine may provide patients with cancer with a broader and stronger protection against COVID-19 variants like omicron, according to a cancer researcher at The Ohio State University Comprehensive Cancer Center.

January 18, 2022

The STELLAR-002 trial is currently underway to examine the combination of XL092, an experimental tyrosine kinase inhibitor, in combination with immuno-oncology therapies for patients with advanced solid tumors.